DEBANANDA PATI to Separase
This is a "connection" page, showing publications DEBANANDA PATI has written about Separase.
Connection Strength
3.328
-
Stability and pharmacokinetics of separase inhibitor-Sepin-1 in Sprague-Dawley rats. Biochem Pharmacol. 2020 04; 174:113808.
Score: 0.680
-
Toxicity study of separase inhibitor-Sepin-1 in Sprague-Dawley rats. Pathol Res Pract. 2020 Jan; 216(1):152730.
Score: 0.672
-
Biology and insights into the role of cohesin protease separase in human malignancies. Biol Rev Camb Philos Soc. 2017 Nov; 92(4):2070-2083.
Score: 0.556
-
Identification and Characterization of Separase Inhibitors (Sepins) for Cancer Therapy. J Biomol Screen. 2014 Jul; 19(6):878-89.
Score: 0.452
-
MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERa)-positive mammary adenocarcinomas. Oncogene. 2014 Nov 27; 33(48):5511-5522.
Score: 0.445
-
Synthesis and activity of benzimidazole-1,3-dioxide inhibitors of separase. Bioorg Med Chem Lett. 2016 09 15; 26(18):4446-4450.
Score: 0.134
-
Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice. PLoS One. 2011; 6(7):e22167.
Score: 0.095
-
Overexpression and mislocalization of the chromosomal segregation protein separase in multiple human cancers. Clin Cancer Res. 2009 Apr 15; 15(8):2703-10.
Score: 0.081
-
Oncogenic activity of separase. Cell Cycle. 2008 Nov 15; 7(22):3481-2.
Score: 0.078
-
Overexpression of Separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A. 2008 Sep 02; 105(35):13033-8.
Score: 0.077
-
Hormone-induced chromosomal instability in p53-null mammary epithelium. Cancer Res. 2004 Aug 15; 64(16):5608-16.
Score: 0.058